Ownership

Sekar Kathiresan - Chief Executive Officer, Director at Verve Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: Chief Executive Officer, Director
Stock Symbol: VERV on Nasdaq
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

Sekar Kathiresan - trading volume in the past year for Verve Therapeutics, Inc.

	Shares	%	Avg Price	Total $
Buys
Sells	-9.82K	100%	$4.15	-$40.8K
Net	-9.82K	-100%		-$40.8K

Holdings reported by Sekar Kathiresan for Verve Therapeutics, Inc.

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	347K	$1.44M	$4.15	Apr 2, 2025	Direct
Common Stock	241K	$1M	$4.15	Apr 1, 2025	Kathiresan Family 2021 Irrevocable Trust
Common Stock	111K	$461K	$4.15	Apr 1, 2025	Sekar Kathiresan 2021 Irrevocable Trust
Restricted Stock Units	99K	$411K	$4.15	Apr 1, 2025	Direct	Common Stock
Stock Option (right to buy)	150K			Jan 8, 2025	Direct	Common Stock

Transactions reported by Sekar Kathiresan for Verve Therapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.